{
  "symbol": "AUROPHARMA.NS",
  "period": "quarterly",
  "data": [
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": 450715100000.0,
      "total_liabilities": 152207100000.0,
      "total_equity": 298508000000.0,
      "total_debt": 66476300000.0,
      "cash_and_equivalents": 33934800000.0,
      "current_assets": 242056300000.0,
      "current_liabilities": 121991300000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.22269520414863253,
      "current_ratio": 1.98420952969597,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2024-06-30",
      "quarter": "Q2 2024",
      "fiscal_year": 2024,
      "revenue": 74576500000.0,
      "gross_profit": 43849700000.0,
      "operating_income": 12153900000.0,
      "ebitda": 18391100000.0,
      "net_income": 9192200000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 16.29722499715058,
      "net_profit_margin": 12.325866727454358,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 24.66071751825307
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2024-09-30",
      "quarter": "Q3 2024",
      "fiscal_year": 2024,
      "revenue": 76462100000.0,
      "gross_profit": 44359400000.0,
      "operating_income": 11838600000.0,
      "ebitda": 17024400000.0,
      "net_income": 8173800000.0,
      "diluted_eps": null,
      "total_assets": 480944500000.0,
      "total_liabilities": 172094900000.0,
      "total_equity": 308849600000.0,
      "total_debt": 84272500000.0,
      "cash_and_equivalents": 39039700000.0,
      "current_assets": 262256400000.0,
      "current_liabilities": 143405800000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.27285934642622167,
      "current_ratio": 1.828771221247676,
      "operating_margin": 15.48296476293484,
      "net_profit_margin": 10.69000197483459,
      "roe": 2.6465308680989064,
      "roa": 1.699530819044609,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 22.26514835454428
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2024-12-31",
      "quarter": "Q4 2024",
      "fiscal_year": 2024,
      "revenue": 78931500000.0,
      "gross_profit": 45777400000.0,
      "operating_income": 12092800000.0,
      "ebitda": 17368600000.0,
      "net_income": 8458100000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 15.320626112515281,
      "net_profit_margin": 10.715747198520235,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 22.004649601236515
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 83811200000.0,
      "gross_profit": 42379600000.0,
      "operating_income": 14395300000.0,
      "ebitda": 18194700000.0,
      "net_income": 9034700000.0,
      "diluted_eps": null,
      "total_assets": 497849700000.0,
      "total_liabilities": 171380400000.0,
      "total_equity": 326469300000.0,
      "total_debt": 82628700000.0,
      "cash_and_equivalents": 55689500000.0,
      "current_assets": 271624600000.0,
      "current_liabilities": 146823400000.0,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": 0.2530979176296209,
      "current_ratio": 1.8500089222835052,
      "operating_margin": 17.17586670993853,
      "net_profit_margin": 10.779824176243748,
      "roe": 2.7673965055826075,
      "roa": 1.814744490154358,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.709151044251843
    },
    {
      "ticker": "AUROPHARMA.NS",
      "date": "2025-06-30",
      "quarter": "Q2 2025",
      "fiscal_year": 2025,
      "revenue": 77917700000.0,
      "gross_profit": 45525500000.0,
      "operating_income": 11977200000.0,
      "ebitda": 17102500000.0,
      "net_income": 8247500000.0,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 20.789072,
      "peg_ratio": null,
      "pb_ratio": 2.030345,
      "ps_ratio": 2.1883788,
      "price_target_high": 1640.0,
      "price_target_low": 730.0,
      "price_target_avg": 1295.9642,
      "promoter_holding": 0.5411,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 4.0,
      "splits": 2.0,
      "buybacks": 580801623,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": 15.371603627930497,
      "net_profit_margin": 10.584886360865374,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 21.949441526123074
    }
  ]
}